Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Généthon

Main focus: Gene therapies and gene editing for the treatment of genetic diseases

Company stage: Clinical

Diseases (gene editing): Sickle cell disease, beta-thalassemia, duchenne muscular dystrophy, lysosomal metabolic diseases

Genome editing tool: CRISPR-Cas9

Funding stage: Private

Location: Évry, Ile-de-France, France

Website: https://www.genethon.com/

Pipeline: https://www.genethon.com/our-therapies/

Généthon is a French company focused on the development of gene therapies directed towards rare diseases. The company develops gene-editing based therapies as well as other types of gene therapies. Its gene-editing activities are centered around haematopoietic stem cells and blood disorders, such as sickle cell disease.

Tags

HashtagGénéthon

Company: Généthon
close
Search CRISPR Medicine